Michael J. Kaufman PhD

Michael Kaufman, Ph. D. is Senior Vice President of CMC at Mersana Therapeutics. He is responsible for all CMC functions related to ADC development, including development and manufacturing activities for antibody, payload-linker, drug substance, and drug product. Previously, Dr. Kaufman served as Vice President, Technical Development at Biogen, Inc. Before Biogen, Dr. Kaufman spent 10 years at Millennium/Takeda, most recently as Vice President, Pharmaceutical Sciences. Before that, he spent 15 years at Merck and Co., Inc. serving in various roles.

Dr. Kaufman received a B.S. in Chemistry from the State University of New York, Stony Brook and a Ph.D. in Physical Organic Chemistry from the University of California, Berkeley. He is the author of over 30 published articles and is named on 10 patents, and has lectured widely in the areas of preformulation, process development, and formulation.